Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.

Ngamskulrungroj P, Chang Y, Sionov E, Kwon-Chung KJ.

MBio. 2012 May 8;3(3). pii: e00103-12. doi: 10.1128/mBio.00103-12. Print 2012.

2.

[Mechanism of Cryptococcus Meningoencephalitis].

Miyazato A.

Med Mycol J. 2016;57(1):J27-32. doi: 10.3314/mmj.57.J27. Review. Japanese.

3.

Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Leongson K, Cousineau-Côté V, Goupil M, Aumont F, Sénéchal S, Gaboury L, Jolicoeur P, Kronstad JW, de Repentigny L.

Infect Immun. 2013 Apr;81(4):1100-13. doi: 10.1128/IAI.01339-12. Epub 2013 Jan 22.

4.

A murine model of Cryptococcus gattii meningoencephalitis.

Thompson GR 3rd, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill JR, Patterson TF.

J Antimicrob Chemother. 2012 Jun;67(6):1432-8. doi: 10.1093/jac/dks060. Epub 2012 Feb 29.

5.

Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans.

Okubo Y, Wakayama M, Ohno H, Yamamoto S, Tochigi N, Tanabe K, Kaneko Y, Yamagoe S, Umeyama T, Shinozaki M, Nemoto T, Nakayama H, Sasai D, Ishiwatari T, Shimodaira K, Yamamoto Y, Kamei K, Miyazaki Y, Shibuya K.

Jpn J Infect Dis. 2013;66(3):216-21.

6.

Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.

Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, Bennett JE, Holland SM, Browne SK, Kwon-Chung KJ.

MBio. 2014 Mar 18;5(2):e00912-14. doi: 10.1128/mBio.00912-14.

7.

Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.

Ikeda-Dantsuji Y, Ohno H, Tanabe K, Umeyama T, Ueno K, Nagi M, Yamagoe S, Kinjo Y, Miyazaki Y.

J Infect Chemother. 2015 Dec;21(12):831-6. doi: 10.1016/j.jiac.2015.08.001. Epub 2015 Oct 23.

PMID:
26477011
8.

Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.

Capilla J, Maffei CM, Clemons KV, Sobel RA, Stevens DA.

Med Mycol. 2006 Nov;44(7):601-10.

PMID:
17071553
9.

Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, Bahn YS.

Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a019760. doi: 10.1101/cshperspect.a019760. Review.

10.

Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease.

Vu K, Tham R, Uhrig JP, Thompson GR 3rd, Na Pombejra S, Jamklang M, Bautos JM, Gelli A.

MBio. 2014 Jun 3;5(3):e01101-14. doi: 10.1128/mBio.01101-14.

11.
12.

Genetic and pathological characteristics of Cryptococcus gattii and Cryptococcus neoformans var. neoformans from meningoencephalitis in autochthonous goats and mouflons, Sardinia, Italy.

Maestrale C, Masia M, Pintus D, Lollai S, Kozel TR, Gates-Hollingsworth MA, Cancedda MG, Cabras P, Pirino S, D'Ascenzo V, Ligios C.

Vet Microbiol. 2015 Jun 12;177(3-4):409-13. doi: 10.1016/j.vetmic.2015.03.008. Epub 2015 Mar 17.

PMID:
25840469
13.

The triple threat of cryptococcosis: it's the body site, the strain, and/or the host.

Perfect JR.

MBio. 2012 Jul 10;3(4). pii: e00165-12. doi: 10.1128/mBio.00165-12. Print 2012.

14.

The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii.

Torda A, Kumar RK, Jones PD.

Pathology. 2001 Nov;33(4):475-8.

PMID:
11827415
15.

Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.

Aminnejad M, Diaz M, Arabatzis M, Castañeda E, Lazera M, Velegraki A, Marriott D, Sorrell TC, Meyer W.

Mycopathologia. 2012 Jun;173(5-6):337-46. doi: 10.1007/s11046-011-9491-x. Epub 2011 Nov 13.

PMID:
22081254
16.

Calcineurin governs thermotolerance and virulence of Cryptococcus gattii.

Chen YL, Lehman VN, Lewit Y, Averette AF, Heitman J.

G3 (Bethesda). 2013 Mar;3(3):527-39. doi: 10.1534/g3.112.004242. Epub 2013 Mar 1.

17.

Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.

Lucas S, da Luz Martins M, Flores O, Meyer W, Spencer-Martins I, Inácio J.

Clin Microbiol Infect. 2010 Jun;16(6):711-4. doi: 10.1111/j.1469-0691.2009.02919.x. Epub 2009 Aug 20.

18.

Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265.

Sorrell TC, Juillard PG, Djordjevic JT, Kaufman-Francis K, Dietmann A, Milonig A, Combes V, Grau GE.

Microbes Infect. 2016 Jan;18(1):57-67. doi: 10.1016/j.micinf.2015.08.017. Epub 2015 Sep 11.

PMID:
26369713
19.

Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure.

Urai M, Kaneko Y, Ueno K, Okubo Y, Aizawa T, Fukazawa H, Sugita T, Ohno H, Shibuya K, Kinjo Y, Miyazaki Y.

Front Cell Infect Microbiol. 2016 Jan 6;5:101. doi: 10.3389/fcimb.2015.00101. eCollection 2015.

20.

Differences between Cryptococcus neoformans and Cryptococcus gattii in the Molecular Mechanisms Governing Utilization of D-Amino Acids as the Sole Nitrogen Source.

Chang YC, Khanal Lamichhane A, Bradley J, Rodgers L, Ngamskulrungroj P, Kwon-Chung KJ.

PLoS One. 2015 Jul 1;10(7):e0131865. doi: 10.1371/journal.pone.0131865. eCollection 2015.

Supplemental Content

Support Center